Laboratory equipment. Photo: Pixabay
May 7, 2021
Sequoia Capital China has led a $40-million Series B round for US-based biotech startup Phanes Therapeutics, while Turn Capital has acquired Taiwanese blockchain startup Dapp Pocket.
Sequoia China leads $40m Series B round for biotech firm Phanes
Phanes Therapeutics, a biotech startup with operations in the US and China, has secured $40 million in a Series B round of financing led by Sequoia Capital China, according to a statement on Thursday.
Chinese private equity firm DYEE Capital; Volcanics Venture, an early-stage venture capital firm that invests in intellectual technology and healthcare; life sciences investor Delos Capital; and Wen Zhou Fund also invested in the new round.